Publications

5803 Results

Quality of Life in Patients <=70 Years of Age with Chronic Lymphocytic Leukemia Treated Frontline with Ibrutinib-Rituximab Versus Fludarabine Cyclophosphamide Rituximab: Analysis from ECOG-ACRIN E1912

Authors
P Pophali;X Wang;F Zhao;N Kay;C Hanson;M Thomas;S O'Brien;J Barrientos;E Paietta;J Leis;C Zhang;S Coutre;P Barr;A Cashen;A Mato;A Singh;R Little;H Erba;R Stone;M Litzow;M Tallman;T Shanfelt;L Wagner;L Wagner;L Wagner
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), poster, #1562
Year
2021
Research Committee(s)
Leukemia
Study Number(s)
CTSU/E1912

Duplex Sequencing for Ultra-Low Frequency Measurable Residual Disease Detection in Adult Acute Myeloid Leukemia

Authors
J Higgins;M Othus;L Dillon;T Smith;E Schmidt;J Yaplee;F Lo;C Valentine;J Salk;C Hourigan;J Radich
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), poster, #3457
Year
2021
Research Committee(s)
Leukemia
Study Number(s)
S0106

A Phase 2 Study of Dasatinib, Prednisone, and Blinatumomab for Elderly Patients with Philadelphia-Chromosome (Ph) Positive or Ph-Like Acute Lymphoblastic leukemia (ALL) (with Dasatinib Sensitive Fusions/ Mutations)

Authors
A Advani;A Moseley;K O'Dwyer;B Wood;J Park;M Wieduwilt;D Jeyakumar;G Yaghmour;E Attalah;A Gerds;S O'Brien;J Liesveld;M Othus;M Litzow;R Stone;E Sharon;H Erba
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), poster, #3397
Year
2021
Research Committee(s)
Leukemia
Study Number(s)
S1318

Risk factors for long-term adjuvant chemotherapy toxicity using pre-treatment host factors and self-rated treatment bother (GP5) in a clinical trial population

Authors
NL Henry;S Kim;R Hays;M Diniz;M Luu;M Tighiouart;R Cecchini;G Yothers;A Rogatko;P Ganz
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 7-10, 2021, San Antonio, TX), spotlight poster discussion, abst 415; PD5-04
Year
2021
Research Committee(s)
Breast

Patient-Reported Outcomes in ECOG-ACRIN EA1131: A randomized phase III trial of platinum vs. capecitabine in patients with residual triple-negative breast cancer after neoadjuvant chemotherapy

Authors
K Smith;F Zhao;I Mayer;A Tevaarwerk;S Garcia;C Arteaga;WF Symmans;B Park;B Burnette;D Makower;M Block;K Morley;C Jani;C Mescher;S Dewani;U Brown-Glaberman;L Flaum;E Mayer;W Sikov;E Rodler;A DeMichele;J Sparano;A Wolff;K Miller;L Wagner
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 7-10, 2021, San Antonio, TX), poster, #P4-10-02
Year
2021
Research Committee(s)
Breast
Study Number(s)
CTSU/EA1131

DREAMSeq Trial: Randomized Phase III Trial of Dabrafenib + Trametinib Followed by Ipilimumab + Nivolumab at Progression VS. Ipilimumab + Nivolumab Followed by Dabrafenib + Trametinib in Patients with Advanced BRAFV600 Mutant Melanoma (EA6134)

Authors
M Atkins;S Lee;B Chmielowski;B Harris;A Ribas;A Tarhini;J Kirkwood
Journal / Conference
ASCO Plenary Series, November 16, 2021, oral
Year
2021
Research Committee(s)
Melanoma
Study Number(s)
CTSU/EA6134

Addressing the Paucity of AYA Clinical Trials Through Pediatric and Adult Partnership

Authors
S Parsons;M Roth
Journal / Conference
AYA Global Congress (December 2, 2021), plenary presentation, oral, no publication
Year
2021
Research Committee(s)
Lymphoma
Study Number(s)
S1826

Predictors of pain reduction in trials of interventions for aromatase inhibitor-associated musculoskeletal symptoms

Authors
NL Henry;JM Unger;C Till;KD Crew;MJ Fisch;DL Hershman
Journal / Conference
JNCI Cancer Spectrum Oct 30;5(6):pkab087. doi: 10.1093/jncics/pkab087. eCollection 2021 Dec
Year
2021
Research Committee(s)
Symptom Management and Survivorship
PMID
PMID34901744
PMC
PMC8660068
Study Number(s)
S0927, S1200, S1202

Advancing traditional PSA kinetics in the detection of prostate cancer: A Machine Learning model

Authors
M Perera;L Smith;IM Thompson;J Breemer;N Pappa;M Patel;M Patel;P Swindle;E Smith
Journal / Conference
European Urology Focus Dec 14;S2405-4569(21)00309-6. doi: 10.1016/j.euf.2021.11.009.
Year
2021
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID34920976
Study Number(s)
SWOG-9217

Survival of Patients with Young-Onset Metastatic Colorectal Cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80405

Authors
M Lipsyc-Sharf;S Zhang;F Ou;N Jackson McCleary;D Niedzwiecki;I Chang;H-J Lenz;CD Blanke;S Piawah;K Van Loon;T Bainter;A Venook;R Mayer;C Fuchs;F Innocenti;A Nixon;R Goldberg;E O'Reilly;J Meyerhardt
Journal / Conference
Journal of the National Cancer Institute Oct 12;djab200. doi: 10.1093/jnci/djab200. Online ahead of print
Year
2021
Research Committee(s)
Gastrointestinal
PMID
PMID34636852
PMC
PMC8902338
Study Number(s)
CTSU/C80405